Chronic Kidney Diseases
706
131
168
320
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
63 trials with published results (9%)
Research Maturity
320 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
30 terminated out of 706 trials
91.4%
+4.8% vs benchmark
10%
73 trials in Phase 3/4
20%
63 of 320 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 320 completed trials
Clinical Trials (706)
System Interventions to Achieve Early and Equitable Transplants (STEPS) Study
Pyrophosphate and Arterial Calcification in Chronic Kidney Disease
Telemonitoring of Hypertensive Patients With Chronic Kidney Disease
Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty
Concomitant Renal and Urinary Bladder Allograft Transplantation
Diurnal BP Patterns in Those at Increased Risk of CVD
Shared Decision Making in Dialysis
Kidney Health: Eat Well, Live Well
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Improving the Collaborative Health of Adult Dyads
Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
Hyperparathyroidism and Dialysis Adequacy in Hemodialysis Patients
AVF Awareness Among Advanced CKD Patients
Partners Calciphylaxis Biobank
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
Keeping RAASi Treatment With Optimal Potassium Control
Subclinical Renal Dysfunction in Rheumatoid Arthritis
Dialysis Geriatric Care Model